|Bid||13.01 x 0|
|Ask||13.07 x 0|
|Day's Range||12.69 - 14.28|
|52 Week Range||2.83 - 16.24|
|Beta (3Y Monthly)||-0.44|
|PE Ratio (TTM)||86.73|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||10.90|
Aurora Cannabis Inc (TSX:ACB) has been soaring since being listed on the TSX, but it may not be a smooth ride from here on out.
Aurora Cannabis Inc (TSX:ACB) has announced that it's ready with high-potency CBD oil cartridges for vaporizers. Time to buy?
Aurora Cannabis Inc. (TSX:ACB) and Aphria Inc. (TSX:APH) are both heading to the NYSE. Is one a better bet today?
TSX: ACB EDMONTON , Oct. 18, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt : 21P; WKN: A1C4WM), announced today that it has filed an ...
Canopy Growth Corp. (TSX:WEED)(NYSE:CGC), down 11.5% since Monday, is still the leader and the marijuana stock with the best risk/reward profile, but beware as reality will surely bite.
Investorsare looking to cash in on a new market are seeing first hand, an industry that generated $8.5 billion on legalmarijuana in the U.S. last year and which is estimated to grow to $23.4 billion in 2022, according to Arcview Market Research and BDS Analytics. PremierHealth Group, Inc. (PHGI.CN), among other things, is targeting acquisitions of clinics, technology and patients in addition to cannabis clinic(s) and partnerships. PremierHealth Group, Inc. (PHGI.CN) completed a CAD $3.55 million financing in August and $1 million was used for the acquisition of HealthVue.
Separately, Aurora Cannabis Inc. and Aphria Inc., the third- and fourth-largest Canadian pot companies by market value, got a boost on their plans to list shares on the New York Stock Exchange. Aurora plans to uplist its over-the-counter shares next week to start trading under ticker ACB, while Aphria also filed its intentions with the SEC.
Tilray (TLRY) stock gained ~11.7% on October 15 to $165 per share. Tilray has been a favorite for speculators, and the stock has experienced wild swings as we saw in September. As of October 15, Tilray was the most valuable cannabis company (HMMJ), ahead of Canopy Growth (WEED) (CGC) and Aurora Cannabis (ACB) (ACBFF). Let’s look at analysts’ recommendations and price targets in October.
Recreational cannabis sales began in Canada on October 17, 2018. Canada is only the second country after Uruguay to legalize cannabis. As a powerful, developed nation, Canada may serve as a blueprint for other developed nations around the world.
EDMONTON — Shares in Aurora Cannabis Inc. will begin trading on the New York Stock Exchange next week.
TSX: ACB EDMONTON , Oct. 18, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt : 21P; WKN: A1C4WM), announced today that its common shares ...
TSX: ACB EDMONTON , Oct. 17, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt : 21P; WKN: A1C4WM) applauds the federal government's ...
Stores in St. John’s, Newfoundland were the first to sell recreational cannabis, followed by more than 100 outlets and websites opening across the country of 37 million people. “I’m super happy, this is an historic day for Canadians and for the world because we’re really setting a precedent here," said Isaac Langille outside a store in Halifax, where he bought the legal limit of 30 grams, spending C$344 ($264) on products from Aphria Inc. and Organigram Holdings Inc.
From a spa that uses CBD to enhance your massage, to make-at-home pot brownies, to cannabis-infused makeup, these entrepreneurs are capitalizing on the green rush.
Today is finally the day. Will short-term issues like approval bottlenecks and product shortages impact pot growers like Canopy Growth Corp (TSX:WEED)(NYSE:CGC) and Aurora Cannabis Inc. (TSX:ACB)?
Aurora Cannabis (ACB) (ACBFF) stock rose by 9.9% to its highest level of 15.1 Canadian dollars on October 15. With just one more day until recreational cannabis will be sold legally in Canada, investors (HMLSF) are hopeful that Aurora Cannabis will emerge as a strong player. Overall, the current consensus analyst recommendation for Aurora Cannabis in October is a “buy,” which remained unchanged from September.
Softgel Sales License Granted at Aurora Vie - New Licenses Significantly Increase Product Availability for Medical and Adult Consumer-Use Markets TSX: ACB EDMONTON , Oct. 17, 2018 /CNW/ - Aurora Cannabis ...
WKN: A1C4WM), is proud to celebrate consumer legalization by commending governments of all levels for their commitment to bringing an end to the prohibition of cannabis for adult consumer use, and acknowledging the decades of activism and effort that have led to this moment. With retail sales beginning in provinces across the country today, Canada is the first G20 country to take this historic, transformative step. "It's a proud day to be Canadian," said Aurora CEO Terry Booth.
TSX: ACB EDMONTON , Oct. 17, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQX: ACBFF) (Frankfurt : 21P; WKN: A1C4WM) announced today that the Company ...
Recreational legalization is a day away and Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) and other cannabis stocks are surging in anticipation of the big roll out.
Without a doubt, Canopy Growth (CGC)(WEED) has been one of the hottest cannabis stocks on the market (MJ). The company is one of the most valuable companies, ahead of Aurora Cannabis (ACB) (ACBFF) and Aphria (APHQF). The overall consensus recommendation for Canopy Growth in October is a “buy.” As the above chart shows, two analysts maintained a “strong buy” on the stock, while five analysts maintained a “buy” recommendation on the stock in the current month.